ARTICLE | Company News
Bristol-Myers, Takeda deal
January 7, 2013 8:00 AM UTC
On Dec. 24, 2012, Takeda said it and Amylin Pharmaceuticals Inc. mutually terminated a 2009 deal to co-develop and commercialize obesity compounds. In 2011, the companies discontinued development of ...